LSC - 2019 - Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma and COPD

M. Roffel (Groningen, Netherlands)

Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Session: Novel mechanisms elucidated by translational studies of COPD
Session type: Poster Discussion
Number: 1668
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Roffel (Groningen, Netherlands). LSC - 2019 - Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma and COPD. 1668

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018



LSC - 2017 - The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Year: 2017



LSC - 2019 - The role of miR-155 in a mouse model of TDI-induced asthma
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019



LSC - 2020 - The role of the COPD susceptibility gene FAM13A in barrier function and pro-inflammatory responses of human airway epithelial cells
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020


Sputum levels of miR-145 and miR-338 in COPD, asthma and ACOS subjects
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015

Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

A role for miR-708-5p in the regulation of chronic mucus hypersecretion
Source: International Congress 2017 – New insights into pathogenesis of lung disease 
Year: 2017

LSC - 2021 - The role of the systemic inflammation in bronchiectasis exacerbation frequency
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021


Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013

Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD
Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases
Year: 2013


Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013

Presence of progranulin in airway inflammation associated with COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

A role for WNT-5B in airway remodeling in COPD by activation of TGF-beta/Smad3 signaling?
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Discovery of candidate proteins, PIGR and SELENBP1, as novel markers of airway diseases in COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013

Polymorphisms in 17q12-21 are associated with asthma exacerbation and lung function in asthmatic children
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011